Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Blood (2022) 140 (Supplement 1): 771–773.

https://doi.org/10.1182/blood-2022-165917

Published: 2022

Journal Articles

Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study

Blood (2017) 130 (Supplement 1): 737.

https://doi.org/10.1182/blood.V130.Suppl_1.737.737

Published: 2017

Journal Articles

The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML

Anne Marie Asemissen, Judith Dierlamm

Blood (2017) 130 (10): 1274.

https://doi.org/10.1182/blood-2017-05-782714

Published: 2017

Journal Articles

Chromosomes 2q, 4q and 13q21 Are Preferential Targets of Epstein-Barr Virus (EBV) Integration In Burkitt's Lymphoma Cell Lines

Eva Maria Murga Penas, PhD, Juliane Hinke, Petra Behrmann, Snjezana Janjetovic, MD, Georgia Schilling, MD, Carsten Bokemeyer, MD, Judith Dierlamm, MD, PhD

Blood (2010) 116 (21): 4452.

https://doi.org/10.1182/blood.V116.21.4452.4452

Published: 2010

Journal Articles

Incidence of ETV6 Cryptic Translocations In Myeloid Disorders

Eva Maria Murga Penas, PhD, Marianne Klokow, Petra Behrmann, Snjezana Janjetovic, MD, Georgia Schilling, MD, Carsten Bokemeyer, MD, Judith Dierlamm, MD, PhD

Blood (2010) 116 (21): 2733.

https://doi.org/10.1182/blood.V116.21.2733.2733

Published: 2010

Journal Articles

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

Blood (2010) 116 (9): 1479–1488.

https://doi.org/10.1182/blood-2010-02-267476

Published: 2010

Includes: Supplemental data

Journal Articles

Response: The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/ API2-MALT1 translocation in MALT lymphomas is not

Eva Maria Murga Penas, Judith Dierlamm

Blood (2010) 115 (17): 3641–3642.

https://doi.org/10.1182/blood-2010-02-266379

Published: 2010

Journal Articles

The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma

Eva Maria Murga Penas, Evelyne Callet-Bauchu, Hongtao Ye, Sophie Gazzo, Françoise Berger, Georgia Schilling, Nadine Albert-Konetzny, Eik Vettorazzi, Gilles Salles, Iwona Wlodarska, Ming-Qing Du, Carsten Bokemeyer, Judith Dierlamm

Blood (2010) 115 (11): 2214–2219.

https://doi.org/10.1182/blood-2009-08-236265

Published: 2010

Journal Articles

Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas

Eva Maria Murga Penas, Evelyne Callet-Bauchu, Nadine Albert, Sophie Gazzo, Françoise Berger, Gilles Salles, Carsten Bokemeyer, Judith Dierlamm

Blood (2008) 112 (11): 4145.

https://doi.org/10.1182/blood.V112.11.4145.4145

Published: 2008

Journal Articles

Functional and Antigenic Detection of Intravascular Tissue Factor (TF).

Florian Langer, Ali Amirkhosravi, Brigitte Spath, Hina Desai, Mildred Amaya, Judith Dierlamm, Barbara Eifrig, John L. Francis, Carsten Bokemeyer

Blood (2006) 108 (11): 4002.

https://doi.org/10.1182/blood.V108.11.4002.4002

Published: 2006

Journal Articles

No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation.

Timon Hansen, Georgia Schilling, MD, Peter Liebisch, MD, Rainer Schwerdtfeger, PD, Jose Antonio Perez-Simon, MD, Martin Bornhaeuser, PD, Svenja Otterstetter, Judith Dierlamm, PD, Arnon Nagler, Dieter Kurt Hossfeld, Carsten Bokemeyer, Axel R. Zander, Nicolaus Kroeger, PD

Blood (2006) 108 (11): 5038.

https://doi.org/10.1182/blood.V108.11.5038.5038

Published: 2006

Journal Articles

Characterization of Bcr-Abl Positive Leukemic Cells under Long-Term In Vitro Treatment with Telomerase Inhibitor BIBR1532.

Ute Brassat, Stefan Balabanov, MD/PhD, Ulrike Hartmann, PhD, Daniel Rössler, Kerstin Borgmann, PhD, Judith Dierlamm, MD/PhD, Tim H. Brummendorf, MD

Blood (2006) 108 (11): 2185.

https://doi.org/10.1182/blood.V108.11.2185.2185

Published: 2006

Journal Articles

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

Djordje Atanackovic, Julia Arfsten, Yanran Cao, Sacha Gnjatic, Frank Schnieders, Katrin Bartels, Georgia Schilling, Christiane Faltz, Christine Wolschke, Judith Dierlamm, Gerd Ritter, Thomas Eiermann, Dieter Kurt Hossfeld, Axel R. Zander, Achim A. Jungbluth, Lloyd J. Old, Carsten Bokemeyer, Nicolaus Kröger

Blood (2006) 109 (3): 1103–1112.

https://doi.org/10.1182/blood-2006-04-014480

Published: 2006

Includes: Supplemental data

Journal Articles

Novel Fusion of the MALT1/MLT and MAP4 Genes Detected in a Diffuse Large B-Cell Lymphoma.

Eva M. Murga Penas, PhD, Kristina Hinz, Petra Behrmann, Martin L. Hansmann, MD, Claudia Becher, Reiner Siebert, MD, Judith Dierlamm, MD, on Behalf of the Network Project “Molecular Mechanisms of Malignant Lymphomas”

Blood (2005) 106 (11): 2838.

https://doi.org/10.1182/blood.V106.11.2838.2838

Published: 2005

Journal Articles

Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation.

Georgia Schilling, MD, Timon Hansen, Jose Antonio Perez-Simon, MD, Rainer Schwerdtfeger, MD, Martin Bornhaeuser, MD, Svenja Otterstetter, Doris Seeger, Judith Dierlamm, PD, Francis Ayuk, MD, Hossfeld Dieter Kurt, Bokemeyer Carsten, Zander R. Axel, Kroeger Nicolaus, PD

Blood (2005) 106 (11): 4338.

https://doi.org/10.1182/blood.V106.11.4338.4338

Published: 2005

Journal Articles

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation

Nicolaus Kröger, Georgia Schilling, Hermann Einsele, Peter Liebisch, Avichai Shimoni, Arnon Nagler, Jose A. Perez-Simon, Jesus F. San Miguel, Michael Kiehl, Axel Fauser, Rainer Schwerdtfeger, Hannes Wandt, Herbert G. Sayer, Han Myint, Hans Klingemann, Tatjana Zabelina, Judith Dierlamm, Axel Hinke, Axel R. Zander

Blood (2004) 103 (11): 4056–4061.

https://doi.org/10.1182/blood-2003-12-4435

Published: 2004

Journal Articles

T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma

Berthold Streubel, Andrea Lamprecht, Judith Dierlamm, Lorenzo Cerroni, Manfred Stolte, German Ott, Markus Raderer, Andreas Chott

Blood (2003) 101 (6): 2335–2339.

https://doi.org/10.1182/blood-2002-09-2963

Published: 2003

Journal Articles

Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes

Judith Dierlamm, Mathijs Baens, Margarita Stefanova-Ouzounova, Kristina Hinz, Iwona Wlodarska, Brigitte Maes, Anja Steyls, Ann Driessen, Gregor Verhoef, Philippe Gaulard, Anne Hagemeijer, Dieter Kurt Hossfeld, Christiane De Wolf-Peeters, Peter Marynen

Blood (2000) 96 (6): 2215–2218.

https://doi.org/10.1182/blood.V96.6.2215

Published: 2000

Journal Articles

Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection

Birgit Alpen, Andreas Neubauer, Judith Dierlamm, Peter Marynen, Christian Thiede, Ekkehard Bayerdörffer, Manfred Stolte

Blood (2000) 95 (12): 4014–4015.

https://doi.org/10.1182/blood.V95.12.4014

Published: 2000

Journal Articles

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene, MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

Judith Dierlamm, Mathijs Baens, Iwona Wlodarska, Margarita Stefanova-Ouzounova, Jesus Maria Hernandez, Dieter Kurt Hossfeld, Christiane De Wolf-Peeters, Anne Hagemeijer, Herman Van den Berghe, Peter Marynen

Blood (1999) 93 (11): 3601–3609.

https://doi.org/10.1182/blood.V93.11.3601

Published: 1999

NARROW

Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study

The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML

Chromosomes 2q, 4q and 13q21 Are Preferential Targets of Epstein-Barr Virus (EBV) Integration In Burkitt's Lymphoma Cell Lines

Incidence of ETV6 Cryptic Translocations In Myeloid Disorders

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

Response: The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/ API2-MALT1 translocation in MALT lymphomas is not

The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma

Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas

Functional and Antigenic Detection of Intravascular Tissue Factor (TF).

No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation.

Characterization of Bcr-Abl Positive Leukemic Cells under Long-Term In Vitro Treatment with Telomerase Inhibitor BIBR1532.

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

Novel Fusion of the MALT1/MLT and MAP4 Genes Detected in a Diffuse Large B-Cell Lymphoma.

Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation.

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation

T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma

Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes

Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene, MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only